Dalibor Blažek

2.0k total citations
22 papers, 1.4k citations indexed

About

Dalibor Blažek is a scholar working on Molecular Biology, Oncology and Virology. According to data from OpenAlex, Dalibor Blažek has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Virology. Recurrent topics in Dalibor Blažek's work include RNA Research and Splicing (8 papers), Genomics and Chromatin Dynamics (6 papers) and DNA Repair Mechanisms (5 papers). Dalibor Blažek is often cited by papers focused on RNA Research and Splicing (8 papers), Genomics and Chromatin Dynamics (6 papers) and DNA Repair Mechanisms (5 papers). Dalibor Blažek collaborates with scholars based in Czechia, United States and Germany. Dalibor Blažek's co-authors include B. Matija Peterlin, Jiří Kohoutek, Koen Bartholomeeusen, Matthias Geyer, Jernej Ule, Zeping Luo, Eric Johansen, Peter Cimermančič, Matjaž Barborič and Christian A. Bösken and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Dalibor Blažek

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalibor Blažek Czechia 17 1.1k 526 203 134 130 22 1.4k
Mayuko Omori United States 10 883 0.8× 294 0.6× 44 0.2× 84 0.6× 76 0.6× 14 1.2k
Björn G. Voldborg Denmark 15 710 0.7× 251 0.5× 138 0.7× 40 0.3× 92 0.7× 31 1.0k
Paola Ferraro Italy 24 1.2k 1.1× 222 0.4× 47 0.2× 189 1.4× 153 1.2× 32 1.6k
S. Peter Klinken Australia 21 894 0.8× 430 0.8× 45 0.2× 90 0.7× 432 3.3× 43 1.6k
Dale S. Haines United States 25 1.2k 1.1× 541 1.0× 60 0.3× 25 0.2× 130 1.0× 45 1.4k
Ian R. Logan United Kingdom 11 823 0.8× 283 0.5× 228 1.1× 21 0.2× 79 0.6× 16 1.0k
Deborah H. Brotherton United Kingdom 11 998 0.9× 396 0.8× 40 0.2× 35 0.3× 82 0.6× 20 1.2k
Mina D. Marmor Israel 9 749 0.7× 450 0.9× 91 0.4× 24 0.2× 233 1.8× 9 1.2k
Kylie A. Hotchkiss United States 12 622 0.6× 224 0.4× 115 0.6× 16 0.1× 136 1.0× 13 1.0k
Seth J. Goldenberg United States 13 1.6k 1.5× 503 1.0× 61 0.3× 17 0.1× 109 0.8× 16 1.8k

Countries citing papers authored by Dalibor Blažek

Since Specialization
Citations

This map shows the geographic impact of Dalibor Blažek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalibor Blažek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalibor Blažek more than expected).

Fields of papers citing papers by Dalibor Blažek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalibor Blažek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalibor Blažek. The network helps show where Dalibor Blažek may publish in the future.

Co-authorship network of co-authors of Dalibor Blažek

This figure shows the co-authorship network connecting the top 25 collaborators of Dalibor Blažek. A scholar is included among the top collaborators of Dalibor Blažek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalibor Blažek. Dalibor Blažek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hegedűsová, Eva, David Potěšil, Prashant Khirsariya, et al.. (2025). CDK7–CDK11 axis in spliceosome regulation and pre-mRNA splicing. Nucleic Acids Research. 53(22).
2.
Blažek, Dalibor, et al.. (2024). CDK11, a splicing-associated kinase regulating gene expression. Trends in Cell Biology. 35(8). 702–716. 4 indexed citations
3.
Mozos, Igor Ruiz de los, Michael Kluge, Benedict‐Tilman Berger, et al.. (2022). CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1. Nature. 609(7928). 829–834. 43 indexed citations
4.
Mozos, Igor Ruiz de los, et al.. (2020). CDK11 is required for transcription of replication-dependent histone genes. Nature Structural & Molecular Biology. 27(5). 500–510. 36 indexed citations
5.
Kluge, Michael, Koen Bartholomeeusen, Jan Oppelt, et al.. (2019). CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes. EMBO Reports. 20(9). e47592–e47592. 72 indexed citations
6.
Paculová, Hana, Tina Lenasi, Vendula Pospíchalová, et al.. (2015). Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex. Nucleic Acids Research. 43(5). 2575–2589. 103 indexed citations
7.
Greifenberg, Ann Katrin, Robert Düster, Koen Bartholomeeusen, et al.. (2015). Structural and Functional Analysis of the Cdk13/Cyclin K Complex. Cell Reports. 14(2). 320–331. 103 indexed citations
8.
Bösken, Christian A., Lucas Farnung, Corinna Hintermair, et al.. (2014). The structure and substrate specificity of human Cdk12/Cyclin K. Nature Communications. 5(1). 3505–3505. 145 indexed citations
9.
Kohoutek, Jiří, et al.. (2014). Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway. Carcinogenesis. 35(11). 2534–2543. 36 indexed citations
10.
Kohoutek, Jiří & Dalibor Blažek. (2012). Cyclin K goes with Cdk12 and Cdk13. Cell Division. 7(1). 12–12. 89 indexed citations
11.
Blažek, Dalibor, Jiří Kohoutek, Koen Bartholomeeusen, et al.. (2011). The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes & Development. 25(20). 2158–2172. 353 indexed citations
12.
Kohoutek, Jiří, Qintong Li, Dalibor Blažek, et al.. (2009). Cyclin T2 Is Essential for Mouse Embryogenesis. Molecular and Cellular Biology. 29(12). 3280–3285. 43 indexed citations
13.
Blažek, Dalibor & B. Matija Peterlin. (2008). Tat-SIRT1 Tango. Molecular Cell. 29(5). 539–540. 44 indexed citations
14.
Kohoutek, Jiří, Dalibor Blažek, & B. Matija Peterlin. (2006). Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters. Proceedings of the National Academy of Sciences. 103(46). 17349–17354. 12 indexed citations
15.
Blažek, Dalibor. (2005). Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb. Nucleic Acids Research. 33(22). 7000–7010. 60 indexed citations
16.
Barborič, Matjaž, Jiří Kohoutek, Jason P. Price, et al.. (2005). Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P‐TEFb. The EMBO Journal. 24(24). 4291–4303. 86 indexed citations
17.
Schulte, Antje, Nadine Czudnochowski, Matjaž Barborič, et al.. (2005). Identification of a Cyclin T-Binding Domain in Hexim1 and Biochemical Analysis of Its Binding Competition with HIV-1 Tat. Journal of Biological Chemistry. 280(26). 24968–24977. 96 indexed citations
18.
Blažek, Dalibor, V. Celer, Iva Navrátilová, & Petr Skládal. (2003). Generation and characterization of single-chain antibody fragments specific against transmembrane envelope glycoprotein gp46 of maedi-visna virus. Journal of Virological Methods. 115(1). 83–92. 21 indexed citations
19.
Blažek, Dalibor & V. Celer. (2003). The production and application of single-chain antibody fragments. Folia Microbiologica. 48(5). 687–698. 24 indexed citations
20.
Celer, V., Dalibor Blažek, Iva Navrátilová, et al.. (2003). Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus. Folia Microbiologica. 48(3). 435–440. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayuko Omori Breakdown of academic impact, for papers by Björn G. Voldborg Breakdown of academic impact, for papers by Paola Ferraro Breakdown of academic impact, for papers by S. Peter Klinken Breakdown of academic impact, for papers by Dale S. Haines Breakdown of academic impact, for papers by Ian R. Logan Breakdown of academic impact, for papers by Deborah H. Brotherton Breakdown of academic impact, for papers by Mina D. Marmor Breakdown of academic impact, for papers by Kylie A. Hotchkiss Breakdown of academic impact, for papers by Seth J. Goldenberg
Rankless by CCL
2026